Compare ICCM & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ICCM | OXBR |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | Israel | Cayman Islands |
| Employees | N/A | N/A |
| Industry | | Property-Casualty Insurers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 8.1M |
| IPO Year | 2013 | 2014 |
| Metric | ICCM | OXBR |
|---|---|---|
| Price | $2.21 | $1.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 89.0K | 22.2K |
| Earning Date | 05-27-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.78 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $2,577,000.00 |
| Revenue This Year | $139.51 | $80.09 |
| Revenue Next Year | $75.66 | $85.22 |
| P/E Ratio | ★ N/A | $72.00 |
| Revenue Growth | N/A | ★ 371.98 |
| 52 Week Low | $0.13 | $0.66 |
| 52 Week High | $9.54 | $2.85 |
| Indicator | ICCM | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 33.57 | 57.54 |
| Support Level | $2.15 | $1.21 |
| Resistance Level | $3.59 | $1.45 |
| Average True Range (ATR) | 0.16 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 10.45 | 95.80 |
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.